HOME > TOP STORIES
TOP STORIES
-
REGULATORY PMDA to Raise Fees and Expand Workforce to Boost Review and Safety Measures, GMP Inspection
January 15, 2019
-
COMMENTARY 2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
January 11, 2019
-
REGULATORY MHLW to Revise Biosimilar Guidelines to Increase Efficiency in Development, Review; Final Draft Expected in FY2019
January 10, 2019
-
REGULATORY MHLW Approves Amgen/Astellas’ Evenity, Gilead Sciences’ Epclusa and More
January 9, 2019
-
BUSINESS Takeda Completes £46 Billion Shire Acquisition
January 8, 2019
-
REGULATORY MHLW to Follow Up on Drug Makers’ Efforts to Observe New Detailing Guidelines
January 7, 2019
-
BUSINESS Can Daiichi Sankyo Take Big Leap in Oncology with 3 FDA Nods in FY2019?
January 4, 2019
-
BUSINESS Reata Developing Sakigake Designated DKD Drug for Alport Syndrome in Japan
December 28, 2018
-
BUSINESS Biogen Japan Set to “Make Impossible Possible” in Next 5 Years, Double Neuroscience Pipeline
December 27, 2018
-
TRENDS Top 10 PHARMA JAPAN Stories in 2018
December 26, 2018
-
BUSINESS Some Drug Makers Stop Distributing 2019 Calendars with Revised JPMA Code of Practice Set to Take Effect in January
December 25, 2018
-
REGULATORY MHLW OKs Add’l Indications for Keytruda, Tecentriq, Hemlibra, and More
December 25, 2018
-
REGULATORY After Settling on October 2019 Re-Pricing, When Will Govt Reveal New Drug Prices?
December 21, 2018
-
REGULATORY PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations
December 20, 2018
-
REGULATORY Govt to Pare Drug Prices by 2.4% in October 2019 Ad-Hoc Re-Pricing
December 19, 2018
-
BUSINESS Takeda Likely to Make NYSE Debut on Christmas Eve
December 19, 2018
-
REGULATORY Ministers Agree on Ad-Hoc Drug Re-Pricing in October 2019, 29 Billion Yen Saving in State Coffers
December 18, 2018
-
COMMENTARY LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
December 17, 2018
-
BUSINESS Astellas Makes Full Inroads into I/O Arena with Potenza Buyout
December 17, 2018
-
BUSINESS Lundbeck Japan to Quadruple Workforce by Next Summer, Eyes Vortioxetine Launch: Chief
December 14, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
